Foot and Ankle Surgery
Volume 15, Issue 4 , Pages 187-191 , December 2009

Long-term outcome and quality of life in patients with Charcot foot

  • Toni-Karri Pakarinen, MD

      Affiliations

    • Department of Orthopaedics and Traumatology, Tampere University Hospital, Teiskontie 35, Tampere 33521, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 3 311 65009; fax: +358 3 311 64369.
    • ,
  • Heikki-Jussi Laine, MD, PhD

      Affiliations

    • Department of Orthopaedics and Traumatology, Tampere University Hospital, Teiskontie 35, Tampere 33521, Finland
    • ,
  • Heikki Mäenpää, MD, PhD

      Affiliations

    • Department of Orthopaedics and Traumatology, Tampere University Hospital, Teiskontie 35, Tampere 33521, Finland
    • University of Tampere, Medical School, Teiskontie 35, Tampere 33521, Finland
    • ,
  • Pentti Mattila, MD

      Affiliations

    • Department of Radiology, Tampere University Hospital, Teiskontie 35, Tampere 33521, Finland
    • ,
  • Jorma Lahtela, MD, PhD

      Affiliations

    • University of Tampere, Medical School, Teiskontie 35, Tampere 33521, Finland
    • Department of Internal Medicine, Tampere University Hospital, Teiskontie 35, Tampere 33521, Finland

Received 1 November 2008 ,Revised 24 January 2009 ,Accepted 13 February 2009.

References 

  1. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366:1719–1724
  2. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–1438
  3. Larsson J, Agardh CD, Apelqvist J, Stenstrom A. Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop. 1998;350:149–158
  4. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extermity amputation in diabetes: the independent effects of peripheral vascular disease, sensory neuropathy and foot ulcers. Diabetes Care. 1999;22:1029–1035
  5. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer The Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036–1042
  6. Pinzur MS, Evans A. Health-related quality of life in patients with Charcot foot. Am J Orthop. 2003;32:492–496
  7. Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL. Arthrodesis as an early alternative to nonoperative management of Charcot arthropathy of the diabetic foot. J Bone Joint Surg. 2000;82A:939–950
  8. Pakarinen T-K, Laine H-J, Honskonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot Current concepts and review of 36 cases. Scand J Surg. 2002;91:195–201
  9. World Health Organization: definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Org.; 1999.
  10. Eichenholz SN. In: Charcot joints. Springfield: Charles C. Thomas; 1966;pp 1–20
  11. Sanders LJ, Frykberg RG. In:  Frykberg RG editors. Diabetic neuropathic osteoarthropathy: the Charcot foot. The high risk foot in diabetes mellitus. New York: Churchill Livingstone; 1991;p. 325–333
  12. Kitaoka HB, Alexander IJ, Adelaar RS, Nunley JA, Myerson MS, Sanders M, et al. Clinical rating systems for ankle—hindfoot, midfoot, hallux, lesser toes. Foot Ankle Int. 1994;15:349–353
  13. Aalto A-M, Aro AR, Teperi J. RAND-36 as a measure of health-related quality of life. Reliability, construct validity and reference values in the Finnish general population. Helsinki, Research Reports 101; 1999.
  14. Salztman CL, Hagy ML, Zimmerman B, Estin M, Cooper R. How effective is intensive nonoperative initial treatment of patients with diabetes and Charcot arthropathy of the feet?. Clin Orthop Relat Res. 2005;435:185–190
  15. Gazis A, Pound N, Macfarlane R, Treece K, Game F, Jeffcoate W. Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot). Diabet Med. 2004;21:1243–1246
  16. Salztman CL, Domsic RT, Baumahauer JF, Deland JT, Gill LH, Hurwitz SR, et al. Foot and ankle research priority: report from Research council of the American Orthopaedic foot and ankle society. Foot Ankle Int. 1997;18:443–446
  17. Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23:796–800
  18. Pinzur MS. Benchmark analysis of diabetic patients with neuropathic (Charcot) foot deformity. Foot Ankle Int. 1999;20:564–567
  19. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13:513–521
  20. American Diabetes Association . Consensus development conference on diabetic foot wound care. Diabetes Care. 1999;22:1354
  21. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999;38:34–40
  22. Yu GV, Hudson JR. Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc. 2002;92:210–220
  23. Shibata T, Tada K, Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg. 1990;72A:749–756
  24. Schon LC, Marks RM. The management of neuroarthropathic fracture—dislocations in the diabetic patient. Orthop Clin North Am. 1995;26:375–392
  25. Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med. 2005;22:1707–1712
  26. Trepman E, Nihal A, Pinzur MS. Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005;26:46–63
  27. Pinzur MS, Sage R, Stuck R, Kaminsky S, Zmuda A. A treatment algorithm for neuropathic (Charcot) midfoot deformity. Foot Ankle. 1993;14:189–197
  28. Pinzur M. Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int. 2004;25:545–549
  29. Brodsky JW, Rouse AM. Exostectomy for symptomatic bony prominences in symptomatic diabetic Charcot feet. Clin Orthop Relat Res. 1993;296:21–26
  30. Laurinavicience R, Kirketerp-Moeller K, Holstein PE. Exostectomy for chronic midfoot plantar ulcer in Charcot deformity. J Wound Care. 2008;17:53–55
  31. Farber DC, Juliano PJ, Cavanagh PR, Ulbrecht J, Cputo G. Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int. 2002;23:130–134
  32. Pinzur MS. Neutral ring fixation for high-risk nonplantigrade Charcot midfoot deformity. Foot Ankle Int. 2007;28:961–966

PII: S1268-7731(09)00028-9

doi: 10.1016/j.fas.2009.02.005

Foot and Ankle Surgery
Volume 15, Issue 4 , Pages 187-191 , December 2009

Article Tools

* Image Usage & Resolution